XML 111 R90.htm IDEA: XBRL DOCUMENT v3.10.0.1
CAPITAL STOCK - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended 67 Months Ended
Jan. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2018
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Options and restricted stock, anti-dilutive (in shares)   5,600,000 7,300,000 4,700,000    
Common stock share purchase, shares (in shares)   40,000,000     40,000,000 40,000,000
Treasury shares acquired (in shares)   7,827,333 0 0 40,000,000  
Common stock share repurchase price (in USD per share)   $ 38.99     $ 79.18  
Common stock dividends (in USD per share)   $ 1.00 $ 1.00 $ 1.00    
Shares authorized and available for grant (in shares)   16,200,000     16,200,000  
Intrinsic value of options exercised   $ 0.1 $ 0.2      
Shares exercised in the period (in shares)   (29,000)   0    
Compensation expense   $ 157.0 142.0 $ 131.0    
Stock-settled and cash-settled compensation capitalized   37.0 41.0 $ 40.0    
Outstanding liability for the unvested awards   177.0 $ 115.0   $ 177.0  
Stock Option            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Total compensation cost related to non-vested awards not yet recognized   6.0     6.0  
Restricted Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Total compensation cost related to non-vested awards not yet recognized   $ 47.0     47.0  
Awards granted during period (in shares)   608,236 1,947,506 4,049,023    
Weighted average grant date fair value per share (in USD per share)   $ 45.59 $ 62.74 $ 47.37    
Compensation expense   $ 101.0 $ 108.0 $ 113.0    
Stock-settled and cash-settled compensation capitalized   $ 29.0 35.0 35.0    
Unvested restricted stock units (in shares)   3,152,801        
Weighted-average remaining life of unvested restricted stock units   8 months        
Total fair value of restricted stock awards vested   $ 111.0 $ 135.0 $ 151.0    
Outstanding liability for the unvested awards   $ 25.0     $ 25.0  
Phantom Units            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Awards granted during period (in shares)   1,973,360        
Subsequent Event | Restricted Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Period in which stock options become exercisable 3 years          
Total compensation cost related to non-vested awards not yet recognized $ 25.0          
Awards granted during period (in shares) 920,043          
Weighted average grant date fair value per share (in USD per share) $ 27.21          
Subsequent Event | Phantom Units            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Total compensation cost related to non-vested awards not yet recognized $ 92.0          
Options issued during the period (in shares) 3,393,772          
Prior to 2016 | Stock Option            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Period in which stock options become exercisable   4 years        
Period in which stock options expires after grant date   10 years        
In or after 2016 | Stock Option            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Period in which stock options become exercisable   3 years        
Period in which stock options expires after grant date   10 years        
ALTM | Subsequent Event | Restricted Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Weighted average grant date fair value per share (in USD per share) $ 7.51          
ALTM | Subsequent Event | Phantom Units            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Total compensation cost related to non-vested awards not yet recognized $ 10.0          
Options issued during the period (in shares) 1,394,526